Advertisement

Topics

Global Cervical Cancer Market 20152019 Prices from USD $2500

02:25 EST 2 Dec 2016 | BioPortfolio Reports

About cervical cancer
Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. It is the world's fourth most common cause of death in women. The disease can be classified as squamous cell carcinoma and adenocarcinoma. Squamous cell carcinoma originates in the lining of the cervix, while adenocarcinoma arises in cervical cells. Cervical cancer is caused due to the infection of HPV. There are no signs and symptoms to identify the early stages of cervical cancer, but it can be identified through regular checkups. Vaginal bleeding and pelvic pain are usually observed as signs and symptoms of cervical cancer. Before cancer detected in the cervix, cervix cells go through changes, called as dysplasia, in which abnormal cells start to expose in the cervical tissue. Over a period, the abnormal cells may developed into cancer cells and begin to grow and spread more deeply into the cervix and surrounding areas.

Technavio's analysts forecast the global cervical cancer market to grow at a CAGR of 4.87% over the period 20142019.

Covered in this report
The report covers the current scenario and the growth prospects of the global cervical cancer market for the period of 20152019. To calculate the market size, the report considers revenue generated through the sales of various drugs used in the treatment and prevention of cervical cancer.

Technavio's report, Global Cervical Cancer Market 20152019, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global cervical cancer market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

Americas
APAC
EMEA
Key vendors

F. HoffmannLa Roche
GlaxoSmithKline
Merck
Other prominent vendors

Advaxis Immunotherapies
Bionor Pharma
Dendreon Corporation
Inovio Pharmaceuticals
ISA Pharmaceuticals
Otsuka Pharmaceuticals
Profectus Biosciences
Virometix
Zeria Pharmaceuticals
Key market driver

Increase in incidence rate
For a full, detailed list, view our report
Key market challenge

Adverse effects of drugs and vaccines
For a full, detailed list, view our report
Key market trend

Patient assistance programs
For a full, detailed list, view our report
Key questions answered in this report

What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Original Article: Global Cervical Cancer Market 20152019 Prices from USD $2500

NEXT ARTICLE

More From BioPortfolio on "Global Cervical Cancer Market 20152019 Prices from USD $2500"

Quick Search
Advertisement
 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...